A detailed history of Acadian Asset Management LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Acadian Asset Management LLC holds 18,111 shares of BSX stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,111
Previous 41,228 56.07%
Holding current value
$1.64 Million
Previous $3.17 Million 52.21%
% of portfolio
0.0%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$72.96 - $84.0 $1.69 Million - $1.94 Million
-23,117 Reduced 56.07%
18,111 $1.52 Million
Q2 2024

Aug 06, 2024

SELL
$67.33 - $77.71 $3.5 Million - $4.04 Million
-52,030 Reduced 55.79%
41,228 $3.17 Million
Q1 2024

May 10, 2024

BUY
$57.6 - $68.62 $2.53 Million - $3.01 Million
43,916 Added 89.0%
93,258 $6.38 Million
Q4 2023

Feb 13, 2024

BUY
$48.64 - $57.81 $1.09 Million - $1.3 Million
22,411 Added 83.22%
49,342 $2.85 Million
Q3 2023

Nov 13, 2023

SELL
$50.19 - $54.68 $3.65 Million - $3.97 Million
-72,673 Reduced 72.96%
26,931 $1.42 Million
Q2 2023

Aug 07, 2023

BUY
$49.72 - $54.64 $4.7 Million - $5.16 Million
94,454 Added 1834.06%
99,604 $5.38 Million
Q1 2023

May 11, 2023

BUY
$45.09 - $50.03 $232,213 - $257,654
5,150 New
5,150 $257,000
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $5.02 Million - $15 Million
-136,686 Reduced 77.86%
38,878 $1.5 Million
Q2 2022

Aug 09, 2022

BUY
$35.24 - $47.1 $6.16 Million - $8.23 Million
174,767 Added 21928.11%
175,564 $6.54 Million
Q1 2022

May 12, 2022

BUY
$40.9 - $45.1 $32,597 - $35,944
797 New
797 $35,000
Q4 2021

Feb 10, 2022

SELL
$38.07 - $44.87 $577,255 - $680,363
-15,163 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$41.23 - $45.88 $91,035 - $101,303
-2,208 Reduced 12.71%
15,163 $656,000
Q2 2021

Aug 11, 2021

BUY
$38.58 - $44.24 $482,828 - $553,663
12,515 Added 257.72%
17,371 $743,000
Q1 2021

May 11, 2021

SELL
$35.27 - $39.67 $344,270 - $387,218
-9,761 Reduced 66.78%
4,856 $187,000
Q4 2020

Feb 11, 2021

SELL
$33.15 - $41.97 $211,231 - $267,432
-6,372 Reduced 30.36%
14,617 $525,000
Q3 2020

Nov 09, 2020

BUY
$34.44 - $42.23 $454,573 - $557,393
13,199 Added 169.44%
20,989 $802,000
Q1 2020

May 11, 2020

BUY
$25.83 - $45.71 $86,427 - $152,945
3,346 Added 75.29%
7,790 $254,000
Q4 2019

Feb 06, 2020

BUY
$37.87 - $45.37 $168,294 - $201,624
4,444 New
4,444 $201,000
Q2 2019

Aug 08, 2019

SELL
$34.91 - $42.98 $89,683 - $110,415
-2,569 Closed
0 $0
Q1 2019

May 09, 2019

SELL
$32.91 - $40.75 $119,759 - $148,289
-3,639 Reduced 58.62%
2,569 $99,000
Q4 2018

Feb 07, 2019

SELL
$31.73 - $39.04 $224,077 - $275,700
-7,062 Reduced 53.22%
6,208 $219,000
Q3 2018

Oct 30, 2018

BUY
$32.83 - $38.63 $226,888 - $266,971
6,911 Added 108.68%
13,270 $511,000
Q2 2018

Jul 24, 2018

BUY
$26.84 - $34.32 $170,675 - $218,240
6,359 New
6,359 $208,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.